Skip to main content

The treatment of Malignant Melanoma by Fast Neutrons

  • Chapter
Basic and Clinical Aspects of Malignant Melanoma

Part of the book series: Cancer Treatment and Research ((CTAR,volume 35))

Abstract

Malignant melanoma is posing an increasing problem in the temperate zones as the incidence is rising and the population presenting with the disease is becoming younger [1]. Conventional treatment has involved wide excision of the lesion with skin grafting which has produced high local control rates for small superficial tumors. However, it is not a satisfactory form of treatment for recurrent or deeply infiltrating tumors or for lesions in sites where wide excision would cause disfigurement or morbidity [2]. For tumors such as these and for widely disseminated disease, alternative forms of therapy have been sought for many years. Radiotherapy, chemotherapy, and immunotherapy have all been studied in clinical trials both alone and as adjuvants to surgery.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ellwood JM: The epidemiology of malignant melanoma. Hospital Update 11:503–514, 1985.

    Google Scholar 

  2. Ackerman AB, Scheiner AM: How wide and deep is wide and deep enough? Hum Pathol 14:743–744, 1983.

    Article  PubMed  CAS  Google Scholar 

  3. Clark WH: In: The histogenesis and biologic behavior of primary human malignant melanomas of the skin, Bernardino EA, Mihm MC (eds). Cancer Res 29:705–726, 1969.

    Google Scholar 

  4. Breslow A: Thickness, cross-sectional area, and depth of invasion in prognosis of cutaneous melanoma. Ann Surg 172:902–908, 1970.

    Article  PubMed  CAS  Google Scholar 

  5. Balch CM, Murad TM, Soong SJ: A multifactorial analysis of melanoma prognostic histopathological features comparing Clark’s and Breslow’s staging methods. Ann Surg 118:732–742, 1978.

    Article  Google Scholar 

  6. Milton GW, Shaw HM, Farago GA, McCarthy WH: Tumour thickness and the site and time of first recurrence in cutaneous malignant melanoma (Stage I). Br J Surg 67:543–546, 1980.

    Article  PubMed  CAS  Google Scholar 

  7. Aitken DR, Clausen K, Klein JP, James AG: The extent of primary melanoma excision. Ann Surg 198:634–641, 1983.

    Article  PubMed  CAS  Google Scholar 

  8. Cassileth BR, Lusk EJ, Tenaglia AN: Patients’ perceptions of the cosmetic impact of melanoma resection. Plast Reconstr Surg 71:73–75, 1983.

    PubMed  CAS  Google Scholar 

  9. Adair FE: The treatment of melanoma. Surg Gynaecol Obstet 62:406–409, 1936.

    Google Scholar 

  10. Tod MC: Radiologic treatment of malignant melanoma. Br J Radiol 19:223–229, 1946.

    Article  PubMed  CAS  Google Scholar 

  11. Mastrangelo M: In: Cancer; principles and practice of oncology, De Vita VT, Hellman S, Rosenberg SA (eds). New York: Lippincott, 1982, p 1132.

    Google Scholar 

  12. Ellis F: The radiosensitivity of malignant melanoma. Br J Radiol 12:327–352, 1939.

    Article  Google Scholar 

  13. Hellriegel W: Radiotherapy of primary and metastatic melanoma. Ann NY Acad Sci 100:131–141, 1963.

    PubMed  CAS  Google Scholar 

  14. Harwood AR, Cummings BJ: Radiotherapy for malignant melanoma; a re-appraisal. Cancer Treat Rev 8:271–282, 1981.

    Article  PubMed  CAS  Google Scholar 

  15. Habermalz H J, Fischer JJ: Radiation therapy of malignant melanoma. Cancer 38:2258–2262, 1976.

    Article  PubMed  CAS  Google Scholar 

  16. Hornsey: The relationship between total dose number of fractions and fraction size in the response of malignant melanoma in patients. Br J Radiol 51:905–909, 1978.

    Article  PubMed  CAS  Google Scholar 

  17. Overgaard J: Radiation treatment of malignant melanoma. Int J Radiat Oncol Biol Phys 11:1837–1839, 1985.

    Article  PubMed  CAS  Google Scholar 

  18. Khan MS, Ross WM: The management of malignant melanoma; a retrospective analysis of 182 patients. Clin Radiol 35:151–154, 1984.

    Article  PubMed  CAS  Google Scholar 

  19. Rofstad EK, Brustad T: Radiosensitivity of the cells of an established human melanoma cell line and the parent melanoma xenograft. Int J Radiat Oncol Biol Phys 44:447–454, 1983.

    CAS  Google Scholar 

  20. Smith IE, Courtenay VD, Mills J, Peckham MJ: In vitro radiation response of cells from four human tumours propagated in immune-suppressed mice. Cancer Res 38:390–392, 1978.

    PubMed  CAS  Google Scholar 

  21. Guichard M, Gosse C, Malaise EP: Survival curve of a human melanoma in nude mice. J Natl Cancer Inst 58:1665–1669, 1977.

    PubMed  CAS  Google Scholar 

  22. Hall EJ: Radiobiology for the radiologist. Maryland: Harper and Row, 1978, p 98.

    Google Scholar 

  23. Hall EJ, Roizin-Towle L, Theus B, August LS: Radiobiological properties of neutrons used in radiotherapy. Radiology 117:173–178, 1975.

    PubMed  CAS  Google Scholar 

  24. Hornsey S, Vatistas W, Bewley DK, Parnell CJ: The effect of fractionation on four day survival of mice after whole-body neutron irradiation. Br J Radiol 38:878–880, 1965.

    Article  PubMed  CAS  Google Scholar 

  25. Read J: The effect of ionisations on the broad bean root; X. The dependance of the x-ray sensitivity on dissolved oxygen. Br J Radiol 25:89–99, 1952.

    Article  PubMed  CAS  Google Scholar 

  26. Gray LH, Conger AD, Ebert M, Hornsey S, Scott OCA: The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. Br J Radiol 26:638–648, 1953.

    Article  PubMed  CAS  Google Scholar 

  27. Thomlinson RH, Gray LH: The histological structure of some human lung cancers and the possible implications for radiotherapy. Br J Cancer 9:539–549, 1955.

    Article  PubMed  CAS  Google Scholar 

  28. Berendsen GW, Koot CJ, van Kersen GR, Bewley DK, Field SB, Parnell CJ: Int J Radiat Biol 10:317, 1967.

    Article  Google Scholar 

  29. Guichard M, Dertinger H, Malaise EP: Radiosensitivity of four human tumour xenografts. Influence of hypoxic and cell-cell contact. Radiat Res 95:602–609, 1983.

    Article  PubMed  CAS  Google Scholar 

  30. van Putten LM, Kallman RF: Oxygenation status of a transplantable tumour during fractionated radiotherapy. J Natl Cancer Inst 40:441–451, 1968.

    PubMed  Google Scholar 

  31. Stone RS: Clinical experience with fast neutron therapy. Am J Roentgenol 59:771–781, 1948.

    CAS  Google Scholar 

  32. Sheline GE, Philips TL, Field SB, Brennan TJ: Effects of fast neutrons on skin. Am J Roentgenol Radiother Nucl Med 111:31–41, 1971.

    CAS  Google Scholar 

  33. Fowler JF, Stern BE: Dose-time relationships in radiotherapy and the validity of cell survival curve models. Br J Radiol 36:163–173, 1963.

    Article  PubMed  CAS  Google Scholar 

  34. Field SB: The relative biological effectiveness of fast neutrons for mammalian tissues. Radiology 93:915–920, 1969.

    PubMed  CAS  Google Scholar 

  35. Catterall M, Bewley DK: Fast neutrons in the treatment of cancer, London: Academic Press, 1979.

    Google Scholar 

  36. Laramore GE, Krall JM, Thomas FJ, Griffin TW, Maor MH, Hendrickson FR: Fast neutron therapy for locally advanced prostate cancer: Results of an RTOG randomised study. Int J Radiat Oncol Biol Phys 11:1621–1627, 1985.

    Article  PubMed  CAS  Google Scholar 

  37. Griffin TW, Davis R, Laramore GE, Maor MH, Hendrickson FR, Rodriguez-Antunez A, Davis L: Mixed beam radiation therapy for unresectable squamous cell carcinomas of the head and neck: The results of a randomised RTOG study. Int J Radiat Oncol Biol Phys 10:2211–2216, 1984.

    Article  PubMed  CAS  Google Scholar 

  38. Griffin TW, Davis R, Hendrickson FR, Maor MH, Laramore GE: Fast neutron therapy for unresectable squamous cell carcinoma of the head and neck: The results of a randomised RTOG study. Int J Radiat Oncol Biol Phys 10:2217–2222, 1984.

    Article  PubMed  CAS  Google Scholar 

  39. Blake PR, Catterall M, Errington RD: Treatment of malignant melanoma by fast neutrons. Br J Surg 72:517–519, 1985.

    Article  PubMed  CAS  Google Scholar 

  40. Bessell EM, Catterall M: The regression of tumours of the head and neck treated with neutrons. Int J Radiat Oncol Biol Phys 9:799–807, 1983.

    Article  PubMed  CAS  Google Scholar 

  41. Duncan W, Arnott S J, Orr JA, Kerr GA: The Edinburgh experience of fast neutron therapy. Int J Radiat Oncol Biol Phys 8:2155–2157, 1982.

    Article  PubMed  CAS  Google Scholar 

  42. Catterall M: Results of neutron therapy. Differences, correlations and improvements. Int J Radiat Oncol Biol Phys 8:2141–2144, 1982.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1987 Martinus Nijhoff Publishers, Boston

About this chapter

Cite this chapter

Blake, P.R. (1987). The treatment of Malignant Melanoma by Fast Neutrons. In: Nathanson, L. (eds) Basic and Clinical Aspects of Malignant Melanoma. Cancer Treatment and Research, vol 35. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2043-2_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-2043-2_10

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-9215-9

  • Online ISBN: 978-1-4613-2043-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics